October 27, 2020 08:28 ET | Source: Research and Markets

Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global market projected to reach USD 14.11 billion by 2025 from USD 10.19 billion in 2020, at a CAGR of 6.7% during the forecast period.

The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

Based on product, the reagents segment holds the highest market share during the forecast period.

Based on product, the research antibodies and reagents market are segmented into reagent and antibodies. The reagent segment accounted for the larger market share in 2019. The reagents market is experiencing notable growth due to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields.

Based on technology, the flow cytometry segment is expected to register the highest CAGR during the forecast period.

Based on technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. The flow cytometry segment is expected to witness the highest growth during the forecast period. This is mainly due to this technique is its ability to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture. It offers a high throughput and the automated quantification of cell features. These factors, along with technological innovations in flow cytometry and growing cancer research, are driving the growth of this segment.

By application, the proteomics holds the highest market share during the forecast period.

Based on application, the research antibodies and reagents market is segmented into proteomics, drug development and Genomics. Proteomics held the largest share of the global research antibodies and reagents market in 2019. The growth of the segment is due to as it efficiently maps drug-protein and protein-protein interactions. Moreover, proteomic technologies have minimized the cost, time, and resource requirements for chemical synthesis and biological testing of drugs. Proteomic technologies, such as electrophoresis, ELISA, microarrays, and MS-based proteomics, are highly efficient for analytical laboratory testing.

By end-user, the pharmaceutical & biotechnology holds the highest market share during the forecast period.

The research antibodies and reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The pharmaceutical & biotechnology companies held the largest share of the global research antibodies and reagents end-user market in 2019. The large share of this segment is attributed to the wide use of research antibodies in drug development for the identification and quantification of biomarkers and various analytical procedures.

By Region, The Asia Pacific region is expected to register the highest CAGR during the forecast period.

The Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR from 2020 to 2025. The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics. Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights 4.1 Research Antibodies and Reagents: Market Overview 4.2 Asia-Pacific: Research Antibodies and Reagents Market, by Application 4.3 Research Antibodies and Reagents Market: Geographic Growth Opportunities 4.4 Research Antibodies and Reagents Market, by Region (2018-2025) 4.5 Research Antibodies and Reagents Market: Developed Vs. Developing Markets

5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing Research Activity and Funding for R&D 5.2.1.2 Growing Industry-Academia Collaboration 5.2.2 Restraints 5.2.2.1 Quality Concerns and a Lack of Reproducible Results 5.2.3 Opportunities 5.2.3.1 Emerging Markets 5.2.3.2 Personalized Medicine and Protein Therapeutics 5.2.3.3 Growth in Stem Cell and Neurobiology Research 5.2.3.4 Increasing Focus on Biomarker Discovery 5.2.3.5 Rising Interest in Outsourcing 5.2.4 Challenges 5.2.4.1 Cost and Time-Intensive Antibody Development Processes 5.2.4.2 Pricing Pressure Faced by Prominent Market Players

6 Industry Insights 6.1 Introduction 6.2 Industry Trends 6.2.1 Increasing Research on Therapeutic Antibodies 6.2.2 Recombinant Antibodies Are Supporting the Smooth Transition from in Vitro to in Vivo 6.2.3 Growing Consolidation of the Life Science Antibodies and Reagents Market 6.3 Stakeholder Analysis 6.4 Strategic Benchmarking 6.5 Impact of COVID-19 on the Research Antibodies and Reagents Market

7 Research Antibodies and Reagents Market, by Product 7.1 Introduction 7.2 Reagents 7.2.1 Media & Sera 7.2.1.1 Media & Sera Hold the Largest Share of the Reagents Market 7.2.2 Stains & Dyes 7.2.2.1 Growth of the Life Science Industry is Driving the Demand and Use of Stains & Dyes 7.2.3 Fixatives 7.2.3.1 Fixative Agents Are Needed to Preserve the Morphology and Antigenicity of Target Molecules 7.2.4 Buffers 7.2.4.1 Wide Use in Drug Development Will Drive the Market for Buffers 7.2.5 Solvents 7.2.5.1 Organic Solvents See Wide Use in Pharmaceutical Processes and Assays Like Ihc 7.2.6 Enzymes 7.2.6.1 An Increase in Proteomic and Genomic Research Activity Will Ensure Demand for Enzymes 7.2.7 Probes 7.2.7.1 the Versatility, Sensitivity, and Quantitative Capabilities of Probes Have Ensured Their Use in Research 7.2.8 Other Reagents 7.3 Antibodies 7.3.1 Antibodies, by Type 7.3.1.1 Primary Antibodies 7.3.1.1.1 Increasing Demand for Accurate and Reliable Antibodies Follows the Rise in R&D Activity and Expenditure 7.3.1.2 Secondary Antibodies 7.3.1.2.1 Versatility and Low Cost of Production Have Ensured Stable Growth in the Market for Secondary Antibodies 7.3.2 Antibodies, by Form 7.3.2.1 Monoclonal Antibodies 7.3.2.1.1 Monoclonal Antibodies Are Among the Most Common Tools in Biomedical Science 7.3.2.2 Polyclonal Antibodies 7.3.2.2.1 Thermo Fisher Scientific and Abcam Are Major Players in the Polyclonal Antibodies Market 7.3.2.3 Recombinant Antibodies 7.3.2.3.1 Recombinant Antibodies Provide a High-Specificity, High-Sensitivity Option 7.3.3 Antibodies, by Source 7.3.3.1 Mice 7.3.3.1.1 Mice Are the Preferred Hosts for Research-Use Antibody Production 7.3.3.2 Rabbits 7.3.3.2.1 Rabbits Are a Cost-Effective Means of Antibody Production 7.3.3.3 Other Sources 7.3.4 Antibodies, by Research Area 7.3.4.1 Oncology 7.3.4.1.1 the High Prevalence of Cancer Has Boosted Research Activity in the Sector 7.3.4.2 Infectious Diseases 7.3.4.2.1 Rising Awareness and Growing Research Activity Are Key Drivers of the Market 7.3.4.3 Immunology 7.3.4.3.1 Antibodies Are Used to Identify Protein and Peptides to Understand Infectious Disease Immunology Better 7.3.4.4 Neurobiology 7.3.4.4.1 Antibody-Based Approaches Are Widely Used in Molecular and Cellular Neuroscience 7.3.4.5 Stem Cells 7.3.4.5.1 Increasing Funding and the Growing Importance of Stem Cells in Transplantation Are Key Market Drivers 7.3.4.6 Other Research Areas

8 Research Antibodies and Reagents Market, by Technology 8.1 Introduction 8.2 Western Blotting 8.2.1 High Accuracy, Ease of Interpretation, and Other Advantages Have Propelled the Use of Western Blotting 8.3 Flow Cytometry 8.3.1 Flow Cytometry is the Fastest-Growing Technology Segment of the Market 8.4 Enzyme-Linked Immunosorbent Assay 8.4.1 Elisa Has the Potential to Supersede the Current Gold Standard for COVID-19 Testing 8.5 Immunohistochemistry 8.5.1 Complexities of Ihc Pose Challenges to Market Growth 8.6 Immunofluorescence 8.6.1 Immunofluorescence Helps Determine Specific Gene Expressions 8.7 Immunoprecipitation 8.7.1 Results Obtained by Ip Can be Analyzed Through Other Technologies 8.8 Other Technologies

9 Research Antibodies and Reagents Market, by Application 9.1 Introduction 9.2 Proteomics 9.2.1 Proteomics Holds the Largest Share of the Market, by Application 9.3 Drug Development 9.3.1 the Drug Development Applications Segment is Expected to Grow at the Highest Rate 9.4 Genomics 9.4.1 Genomics is Currently An Emerging Area of Research Applications and Expected to See Growth in the Coming Years

10 Research Antibodies and Reagents Market, by End-user 10.1 Introduction 10.2 Pharmaceutical & Biotechnology Companies 10.2.1 Pharma & Biotech Companies Dominate the End-User Market 10.3 Academic & Research Institutions 10.3.1 Growing Government Investments to Propel the Market 10.4 Contract Research Organizations 10.4.1 Growing Work on Monoclonal Antibodies and Drug Conjugates Among Cros is Aiding Market Growth

11 Research Antibodies and Reagents Market, by Region 11.1 Introduction 11.2 North America 11.3 Europe 11.4 Asia-Pacific 11.5 Latin America 11.6 Middle East and Africa

12 Competitive Landscape 12.1 Overview 12.2 Matrix Evaluation Framework 12.3 Research Antibodies Market Share Analysis 12.4 Competitive Leadership Mapping 12.4.1 Stars 12.4.2 Emerging Leaders 12.4.3 Pervasive Companies 12.4.4 Emerging Companies 12.5 Competitive Situation and Trends 12.5.1 Product Launches 12.5.2 Expansions 12.5.3 Acquisitions 12.5.4 Collaborations, Partnerships, and Agreements

13 Company Profiles 13.1 Thermo Fisher Scientific 13.2 Merck Group 13.3 Abcam plc 13.4 Becton, Dickinson and Company 13.5 Cell Signaling Technology 13.6 Bio-Rad Laboratories 13.7 F. Hoffmann-La Roche 13.8 Agilent Technologies 13.9 Danaher Corporation 13.10 Lonza 13.11 Genscript 13.12 PerkinElmer 13.13 Biolegend 13.14 Illumina 13.15 Immunoprecise Antibodies 13.16 Fujirebio Diagnostics Ab 13.17 Analytik Jena Ag 13.18 Omega Bio-Tek 13.19 Dovetail Genomics 13.20 Atlas Antibodies

14 Appendix 14.1 Insights of Industry Experts 14.2 Discussion Guide 14.3 Knowledge Store: Subscription Portal 14.4 Available Customizations 14.5 Related Reports 14.6 Author Details

For more information about this report visit https://www.researchandmarkets.com/r/h35zte

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

See the original post:
COVID-19 Impact on the Research Antibodies & Reagents Market by Product, Technology, Application, End-user - Global Forecast to 2025 -...